Anticorps Monoclonal anti-SLC1A5/ASCT2

SLC1A5/ASCT2 Monoclonal Antibody for WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1C4E1

N° de cat : 68540-1-PBS

Synonymes

SLC1A5, 1C4E1, AAAT, ASCT2, ATB(0)



Informations sur le produit

68540-1-PBS cible SLC1A5/ASCT2 dans les applications de WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène SLC1A5/ASCT2 Protéine recombinante Ag16837
Nom complet solute carrier family 1 (neutral amino acid transporter), member 5
Masse moléculaire calculée 541 aa, 57 kDa
Poids moléculaire observé 55-70 kDa
Numéro d’acquisition GenBankBC000062
Symbole du gène SLC1A5/ASCT2
Identification du gène (NCBI) 6510
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

SLC1A5 (Solute Carrier Family 1, member 5), also named as ASCT2, a major glutamine transporter belonging to the SLC1 family and localized in the plasma membrane of several body districts. Consistent with the functions exerted by glutamine, SLC1A5 is involved in uptake of essential amino acids, activation of mTORC1 and glutamine-dependent tumor cell survival and growth. SLC1A5 is highly expressed in various malignancies and plays a critical role in the transformation, growth and survival of cancer cells (PMID: 30234109). High SLC1A5 expression is associated with poor prognosis in clear-cell renal cell carcinoma (PMID: 26599282).

{{ptg:RelatedPrimaryAntibodies}}